Breast Flashcards

1
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Breast cancer RFx

A
  • FEMALE
  • Increased OESTROGEN (early menarche + late menopase)
  • More glandular tissue
  • OBESITY
  • ALCOHOL (metabolised into carcinogen) / SMOKING
  • 1ST DEGREE RELATIVE (FHx)

cOCP + HRT (esp combined)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Breast Cancer pathophys

A

BRCA (BReast CAncer) gene = tumour suppressor -> mutation = cancer

  • BRCA1 (chromosome 17)
    • 70% breast cancer by 80 + 50% ovarian
    • bowel + prostate
  • BRCA2 (chromosome 13)
    • 60% breast by 80 + 20% ovarian
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of breast cancer

A
  • Ductal carcnioma in situ
  • lobular carcinoma in situ
  • Invasive ductal carcinoma (no specific type - NST)
  • Invasive lobular carcinoma
  • Inflam breast cancer
  • Paget’s disease of Nipple

Rare:
Medullary breast cancer
Mucinous breast cancer
Tubular breast cancer
+ more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Breast Cancer screening

A

NHS -> MAMMOGRAM every 3 YEARS for everyone 50-70 Y/O (post-menopausal typically)

Then call back + thermography if something seems unusual

Can also use a MRI in complex cases (useful in ppl with implants too)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Downsides to breast cancer screening

A
  • Anxiety and stress
  • Exposure to radiation, with a very small risk of causing breast cancer
  • Missing cancer, leading to false reassurance
  • Unnecessary further tests or treatment where findings would not have otherwise caused harm
  • Expensive

But benefits outweigh risks usually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which people are high-risk for breast cancer

A

People with significant FHx:

  • 1st degree relative under 40
  • 1st degree male relative
  • 1st degree relative with bilateral breast cancer diagnosed under 50
  • 2 or more 1st degree relatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Interventions for women at high-risk of breast cancer

A

Secondary care clinic or specialist genetic clinic

  • can get genetic testing (need genetic and pre-test counselling)

Get ANNUAL mammogram

May use CHEMOPREVENTION:
- Tamoxifen (premenopause)
- Anastrozole (postmenopause - CI if severe osteoporosis)

Risk -reducing bilateral mastectomy or oophrectomy (less common)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical features suggestive of breast cancer

A
  • Lumps: HARD, IRREGULAR, PAINLESS or FIXED
    • may be tethered to skin/chest wall
  • NIPPLE RETRACTION
  • Skin dimpling (peau d’orange)
  • LYMPHADENOPATHY (esp axilla)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When is a 2 week wait referral recommended for breast cancer

A
  • An unexplained breast lump in patients aged 30 or above
  • Unilateral nipple changes in patients aged 50 or above (discharge, retraction or other changes)

Consider for:
- unexplained axilla lump in over 30s
- indicative skin changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the algorithm for once someone gets a 2 week referral for breast ca

A

Triple diagnostic assessment:

  • Clinical assessment (history and examination)
  • Imaging (ultrasound or mammography)
    - also of lymphnodes in the axilla + to guide biopsy of any abnormal nodes
  • Biopsy (fine needle aspiration or core biopsy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

USS vs mammography for breast cancer

A
  • USS better for younger women (have more glandular tissue)
    • good to distinguish between solid and cystic
  • Mammogram better for older
    • can pick up calcifications

Can also use MRI for screening high-risk or to further assess tumour dimensions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a sentinal node biopsy

A

A sentinal node is the first node in the lymphatic drainage of a tumour area

Injecting isotope contrast and dye into tumour area highlights the sentinal node. A biopsy can be taken and nodes removed if cancer found.

Done if initial USS shows no abnormal nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Breast Cancer Receptors

A

Oestrogen receptors (ER)
Progesterone receptors (PR)
Human epidermal growth factor (HER2)

Treatment depends on which is present. Cancer can be triple negative = worse prognosis,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where can breast cancer metastesise

A

Anywhere in body. But Main sides are:

  • LUNGS
  • LIVER
  • BRAIN
  • BONES
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Breast Cancer Tx

A
  • Surgery
    • Breast conservation + radiotherapy
    • Mastectomy
    • Axillary clearance (SE: chronic Lymphoedema)
  • Adjuvent Radiotherapy (SE: fatigue, irritation, fibrosis, shrinking)
  • Chemo (typically if sensitive):
    • Neoadjuvant
    • Adjuvant
    • treat mets/recurrance
  • Hormone therapy (for 5-10 years)
    • Tamoxifen, goserelin (- a GnRH agonist) (premonopause) (SE: risk of endometrial cancer)
    • Aromatase inhib (postmenopause)
  • Adjuvent bisphosphonates in postmenopausal women
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tamoxifen MOA

A

Selective oestrogen receptor modulator (SERM)

Blocks oestrogen receptors in breast tissue, and stimulates oestrogen receptors in the uterus and bones

helps prevent osteoporosis, but it does increase the risk of endometrial cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Aromatase inhib MOA

A

Aromatase is found in fat - converts androgens to oestrogen -> primary oestrogen sourse post-menopause

Inhibs stop oestrogen production in fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Examples of targeted therapy for breast cancer

A

Basically just HER2 Ab

Trastuzumab (Herceptin) is a monoclonal antibody that targets the HER2 receptor. It may be used in patients with HER2 positive breast cancer. Notably, it can affect heart function; therefore, initial and close monitoring of heart function is required.

Pertuzumab (Perjeta) is another monoclonal antibody that targets the HER2 receptor. It may be used in patients with HER2 positive breast cancer. This is used in combination with trastuzumab (Herceptin).

Neratinib (Nerlynx) is a tyrosine kinase inhibitor, reducing the growth of breast cancers. It may be used in patients with HER2 positive breast cancer.

20
Q

Types of breast reconstruction

A

After breat-conserving surg:

  • Partial reconstruction (using a flap or fat tissue to fill the gap)
  • Reduction and reshaping (removing tissue and reshaping both breasts to match)

Mastectomy:

  • Breast implants (inserting a synthetic implant)
  • Flap reconstruction (using tissue from another part of the body to reconstruct the breast)
21
Q

Breast implants pros + cons

A

Pros:
- simple
- minimal scarring

Cons:
- Less natural
- Long term problems
- Hardening
- Leakage
- Shape change

22
Q

Types of flap breast reconstruction

A
  • Latissimus Dorsi Flap
  • Transverse Rectus Abdominis Flap (TRAM Flap)
  • Deep Inferior Epigastric Perforator Flap (DIEP Flap)
23
Q

Pedicled vs Free flap

A

“Pedicled” - keeping the original blood supply and moving the tissue under the skin to a new location.

“Free flap” - cutting the tissue away completely and transplanting it to a new location.

24
Q

In situ breast carcinoma defination

A

non-invasive breast cancer that is confined to the duct or lobule in which it originated and does not extend beyond the basement membrane

Potential precursor to invasive carcinoma

25
Q

Types of breast carcinoma in situ

A

Ductal Carcinoma In Situ (DCIS)

Lobular Carcinoma In Situ (LCIS)
- classical
- pleomorphhic
- florid

26
Q

Ductal Carcinoma In Situ (DCIS)

A
  • Pre-cancerous or cancerous epithelial cells of the breast ducts
  • Localised to a single area
  • Often picked up by mammogram screening
  • Potential to spread locally over years
  • Potential to become an invasive breast cancer (around 30%)
  • Good prognosis if full excised and adjuvant treatment is used
27
Q

Lobular Carcinoma In Situ (LCIS)

A
  • Pre-cancerous condition occurring typically in pre-menopausal women
  • Usually asymptomatic and undetectable on a mammogram
  • Usually diagnosed incidentally on a breast biopsy
  • increased risk of invasive breast cancer in the future (around 30%)
  • Often managed with close monitoring (e.g., 6 monthly examination and yearly mammograms)
28
Q

Paget’s Disease of the Nipple

A
  • Looks like eczema of the nipple/areolar
  • Erythematous, scaly rash
  • Indicates breast cancer involving the nipple
  • May represent DCIS or invasive breast cancer
  • Requires biopsy, staging and treatment, as with any other invasive breast cancer
29
Q

Breast abscess

A

Collection of PUS within breast, usually caused by BACTERIAL INFECTION

Can be lactational (related to breastfeeding) or non-lactational

30
Q

Abscess pathophys

A

Inflam -> PUS -> trapped -> abscess

31
Q

RFx for mastitis/abscesses

A
  • SMOKING
  • Damage to nipple (eczema, piercings, candida)
  • Underlying breast disease (e.g. cancer) affecting DRAINAGE
32
Q

Most common causative organisms of breast absecess

A
  • Staphylococcus aureus (the most common)
  • Streptococcal species
  • Enterococcal species
  • Anaerobic bacteria (such as Bacteroides species and anaerobic streptococci)
33
Q

Mastitis/breast abscess Sx

A

If infection is present:

  • Nipple changes
  • Purulent DISCHARGE
  • PAIN + TENDERNESS
  • Warmth, Erythema, Swelling
  • HARDENING OF SKIN/TISSUE

KEY FEATURE of BREAST ABSCESS = swollen, tender lump which i FLUCTUANT (fluid moves on palpation)

+/- general symps e.g. myalgia, fatigue, fever, septic

34
Q

Mastitis management

A

Lactational = conservative
- continue breastfeeding
- express milk
- breast massage
- Warm packs/showers + analgesia for symps

Non-lactational
- Analgesia
- ANTIBIOTICS (broad spec as can be aerobic or anaerobic -> CO-AMOX or MACROLIDES AND METRONIDAZOLE)
- Treat underlying causes (eczema, candida)

35
Q

Breaset abscess management

A
  • Referral to the on-call surgical team
  • Antibiotics
  • Ultrasound (confirm the diagnosis and exclude other pathology)
  • Drainage (needle aspiration or surgical incision and drainage)
  • MS+C of drained fluid
36
Q

Fibroadneoma

A

Small, MOBILE benign tumours of stromal/epithelial breast duct tissue

More common in 20-40 y/o (due to response to female hormones)

37
Q

On examination, fibroadenomas are:

A

Painless
Smooth
Round
Well circumscribed (well-defined borders)
Firm
Mobile (moves freely under the skin and above the chest wall)
Usually up to 3cm diameter

38
Q

Breast cysts

A

Benign, individual, fluid-filled lumps - most common cause of lumps.

Typically in 30-50 y/o

39
Q

On examination, breast cysts are:

A
  • Smooth
  • Well-circumscribed
  • Mobile
  • Possibly fluctuant

Can be painful and fluctuate in size with menstrual cycle

40
Q

Management of breast cysts

A

further assessment to exclude cancer (may slightly increase risk), with imaging and potentially aspiration or excision.

  • Aspiration can resolve pain
41
Q

What is included in a triple assessment for breast cancer

A

Clinical score 1-5 (1 = norm; 5 = malignant)
Imaging score 1-5
Biopsy score 1-5

Aim for concordence in MDT

42
Q

When would you do mastectomy vs Breast conservation

A
  • Extensive disease through breast
  • THe lump is too large in relation to the breast to be able to conserve (tho can use neoadjuvent chemo to shrink first and then do conservation therapy)
  • preferance of the individual
43
Q

Grade vs stage

A

Grade - how abnormal cancer looks down microscope + how likely it is to progress

Stage - the anatomical extent

44
Q

What genetic factors affect breast cancer Tx succes

A
  • Oestrogen sensitivity
  • Progesteron sensitivity
  • Herceptin sensitivity
45
Q

Factors to consider if considering chemo for more complex breast cancer

A
  • Young age
  • Oestrogen receptor +ve
  • High grade
  • Node positive
  • Ki67 pos
  • ## Tumour size